Biotech
Latest Washington DC stories tagged “Biotech”.
Gaithersburg biotech regains compliance with Nasdaq amid merger
DC Business
•
Sep 19, 2019
United Therapeutics advances new pulmonary hypertension treatment to FDA review
DC Business
•
Sep 11, 2019
This Rockville biotech has added another deal to its growth plan
DC Business
•
Sep 9, 2019
Gaithersburg's OpGen to combine with German molecular diagnostic company
DC Business
•
Sep 5, 2019
Md. biotech files to go public with $150M offering
DC Business
•
Aug 30, 2019
Viela Bio clears another hurdle to get rare disease drug to market
DC Business
•
Aug 27, 2019
Md. Tech Council CEO wants state biotech industry to aim higher than top 3
DC Business
•
Aug 20, 2019
Need lab space? This Rockville research group is taking proposals.
DC Business
•
Aug 20, 2019
FDA rejects Vanda's drug application for jet lag disorder
DC Business
•
Aug 19, 2019
Amgen and Sysco rise while Viacom and Bank of America fall
DC Politics
•
Aug 12, 2019
Novavax looks to next flu vaccine trial following sale of manufacturing business
DC Business
•
Aug 7, 2019
This D.C. biotech has hit some bumps this year. It's also breaking revenue records.
DC Business
•
Aug 2, 2019
This Rockville biotech is snapping up licensing deals. And it's not done.
DC Business
•
Aug 1, 2019
FDA points to deficiencies in Vanda's latest drug application
DC Business
•
Jul 22, 2019
Try These 5 Things When You First Start CBD Gummies (Because Of Science)
DC Business
•
Jul 18, 2019
Nausea no more? D.C. biotech gets motion sickness drug to next stage.
DC Business
•
Jul 17, 2019
Not just a vaccine company: How this Gaithersburg biotech CEO plans to grow the business
DC Business
•
Jul 12, 2019
Sexual harassment lawsuit against Md. biotech to advance with plaintiff's identity revealed
DC Business
•
Jul 11, 2019
Altimmune to acquire California company for up to $93M
DC Business
•
Jul 9, 2019
Novavax selling manufacturing business amid good news for flu vaccine
DC Business
•
Jun 27, 2019
Viela Bio secures $75M Series B round. It's getting closer to bringing its lead candidate to market.
DC Business
•
Jun 17, 2019
Novavax still plans to push RSV vaccine to market after failed trial
DC Business
•
Jun 10, 2019